Yes, but if one compares to Sirtex, Sirtex sold 67,000 doses by 2016 in over 40 countries. And the Sirtex device was also used in combination with chemo.
So, again there is no real intrinsic reason why Oncosil could not be as successful.
Oncosil is already getting close to 40 country adoptions.
EU member states: 27 UK: 1 Singapore: 1 Malaysia: 1 Switzerland: 1 NZ: 1
Adoptions Pending:
Aus: 1 Hong Kong: 1
US: Bile Duct
To sum up: 32 countries already approved. And another 3 to go.
Thumbs up if you like the analysis.
OSL Price at posting:
16.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)